Ross Muken
Stock Analyst at Evercore ISI Group
(2.75)
# 1,263
Out of 4,667 analysts
43
Total ratings
55.56%
Success rate
4.65%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Muken
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: In-Line | $190 → $225 | $187.90 | +19.74% | 6 | Nov 7, 2024 | |
| PDCO Patterson Companies | Maintains: In-Line | $23 → $22 | $20.06 | +9.67% | 3 | Oct 8, 2024 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $360 → $350 | $203.67 | +71.85% | 7 | Oct 8, 2024 | |
| HSIC Henry Schein | Maintains: In-Line | $70 → $74 | $73.73 | +0.37% | 8 | Oct 8, 2024 | |
| A Agilent Technologies | Maintains: In-Line | $126 → $130 | $128.57 | +1.11% | 11 | Jul 2, 2024 | |
| QGEN Qiagen | Downgrades: In-Line | n/a | $42.09 | - | 2 | Jul 16, 2019 | |
| CAH Cardinal Health | Initiates: In-Line | $67 | $120.34 | -44.32% | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | $250 | $131.68 | +89.85% | 2 | Jan 4, 2018 | |
| TMO Thermo Fisher | Initiates: Outperform | $220 | $512.84 | -57.10% | 1 | Jan 4, 2018 | |
| MBLY Mobileye | Downgrades: In-Line | n/a | $16.92 | - | 1 | Mar 13, 2017 |
Charles River Laboratories International
Nov 7, 2024
Maintains: In-Line
Price Target: $190 → $225
Current: $187.90
Upside: +19.74%
Patterson Companies
Oct 8, 2024
Maintains: In-Line
Price Target: $23 → $22
Current: $20.06
Upside: +9.67%
ICON Public Limited Company
Oct 8, 2024
Maintains: Outperform
Price Target: $360 → $350
Current: $203.67
Upside: +71.85%
Henry Schein
Oct 8, 2024
Maintains: In-Line
Price Target: $70 → $74
Current: $73.73
Upside: +0.37%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126 → $130
Current: $128.57
Upside: +1.11%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $42.09
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $120.34
Upside: -44.32%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $131.68
Upside: +89.85%
Thermo Fisher
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $512.84
Upside: -57.10%
Mobileye
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $16.92
Upside: -